Delivery Order SPE2DB25D3108-SPE2DB25FPCFM

Award Date 2/27/25
Potential Completion Date 2/28/25
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 0.25 mg/0.5 ml Wegovy pens, a medication for the treatment of obesity. The contract has a ceiling value of $5,588.37 and runs through March 4, 2025. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a medication used in the treatment of obesity. The contract has a ceiling value of $3,842.83 and a completion date of December 19, 2023. It is a Firm Fixed Price Delivery Order contract with no set-aside designation, indicating open competition....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 0.25 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract has a ceiling value of $37,356.40 and is a firm fixed-price delivery order with a completion date of November 15, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a...
This federal contract award, valued at $6,630.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a medication used in the treatment of chronic weight management. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type and has an ultimate completion date of April 25, 2024. It is not designated as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Wegovy 0.5 mg/0.5 ml pens. The $2,194.16 firm fixed-price delivery order has a completion date of June 27, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive...
This federal contract award, valued at $2,864.43, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a medication used for chronic weight management. The contract is a delivery order and has a firm fixed price pricing type. It is not designated as a set-aside contract. The ultimate completion date for this contract is February 28,...
This federal contract award is for the delivery of Wegovy 1.7 mg/0.75 ml pens in 0.75 ml quantities to the Defense Logistics Agency (DLA). The $1,714.73 Firm Fixed Price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on August 20, 2024 with a completion date of August 21, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Wegovy 1 mg/0.5 ml pens. The contract, valued at $4,186.72, is a Firm Fixed Price Delivery Order with an ultimate completion date of August 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to...
This federal contract award, valued at $1,228.50, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Wegovy 2.4 mg/0.75 ml pens, a specialty medication used for weight management. The award is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is for the delivery of Wegovy 1 mg/0.5 ml pens, a specialty medication for the treatment of obesity. The award is a Firm Fixed Price Delivery Order with a ceiling value of $14,800.24 and an ultimate completion date of November 15, 2021. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
  • SPE2DB25D3108
    Indefinite Delivery Contract
  • SPE2DB25D3108-SPE2DB25FPCFM
    Delivery Order

This federal contract award, valued at $4,089.54, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Wegovy 0.5 mg/0.5 ml pens, a medication used for the treatment of obesity.

The contract is a Firm Fixed Price Delivery Order that runs through February 28, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 6/1/25, 3:14 AM